Catalent Inc
NYSE:CTLT
Catalent Inc
Net Issuance of Common Stock
Catalent Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Net Issuance of Common Stock
$4m
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
15%
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Common Stock
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Common Stock
-$4.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Catalent Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
4m
USD
Based on the financial report for Dec 31, 2023, Catalent Inc's Net Issuance of Common Stock amounts to 4m USD.
What is Catalent Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
15%
Over the last year, the Net Issuance of Common Stock growth was -50%. The average annual Net Issuance of Common Stock growth rates for Catalent Inc have been -85% over the past three years , -61% over the past five years , and 15% over the past ten years .